TickerFacts.

Advanced Biomed Inc. (ADVB): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$343.8K
Year ended 2025-06-30
$399.6K2024-06-30: $399.6K2025-06-30: $343.8K$343.8K
2024-06-30 Depreciation & Amortization (USD) 2025-06-30
Period endedDepreciation & AmortizationChange YoYSource filing
2025-06-30$343.8K-14.0%2025-10-08, From 2024-07-01
2024-06-30$399.6Kn/a2025-10-08, From 2023-07-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Advanced Biomed Inc. (ADVB)2025-06-30$343.8K-14.0%
Renalytix plc (RNLXY)2024-06-30$364.0K-28.3%
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31$17.5K-49.3%
Aclarion, Inc. (ACON)2025-12-31$227.4K+17.7%
American Shared Hospital Services (AMS)2025-12-31$5.71M-7.5%
Exagen Inc. (XGN)2025-12-31$2.10M+23.5%
Biodesix Inc (BDSX)2025-12-31$5.67M-1.8%
Sera Prognostics, Inc. (SERA)2025-12-31$940.0K+12.8%
Personalis, Inc. (PSNL)2025-12-31$10.05M-8.2%

Compare ADVB, RNLXY, FCHS, ACON side by side · Screen every company in Services-Medical Laboratories ↗